Skip to content
← Back to this collection

PUBLICATIONS · 29672223

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Jun 1
First author
Maurer MJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Leuk Lymphoma. 2019 Mar;60(3):839-841. doi: 10.1080/10428194.2018.1508671.
    note
    Source null
    related pmid
    30234405
    relationship
    Comment in

Authors and identifiers

  1. name
    Maurer MJ
    type
    Author
  2. name
    Ghesquières H
    type
    Author
  3. name
    Link BK
    type
    Author
  4. name
    Jais JP
    type
    Author
  5. name
    Habermann TM
    type
    Author
  6. name
    Thompson CA
    type
    Author
  7. name
    Haioun C
    type
    Author
  8. name
    Allmer C
    type
    Author
  9. name
    Johnston PB
    type
    Author
  10. name
    Delarue R
    type
    Author
  11. name
    Micallef IN
    type
    Author
  12. name
    Peyrade F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Maurer MJ
    type
    Author
  2. name
    Ghesquières H
    type
    Author
  3. name
    Link BK
    type
    Author
  4. name
    Jais JP
    type
    Author
  5. name
    Habermann TM
    type
    Author
  6. name
    Thompson CA
    type
    Author
  7. name
    Haioun C
    type
    Author
  8. name
    Allmer C
    type
    Author
  9. name
    Johnston PB
    type
    Author
  10. name
    Delarue R
    type
    Author
  11. name
    Micallef IN
    type
    Author
  12. name
    Peyrade F
    type
    Author
bibliography ids
  1. nci-bib-92025849dca43aac5ad126bd
book metadata
content sha256
27783ddc9845fe678010cf65944fa1037d3fd75e84fc143055c533fde371d771
document type
citation
dois
  1. 10.1200/JCO.2017.76.5198
electronic publication date
display
2018 Apr 19
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29672223
immutable id
pubmed:29672223@27783ddc9845fe678010cf65944fa1037d3fd75e84fc143055c533fde371d771
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
16
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1603-1610
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Leuk Lymphoma. 2019 Mar;60(3):839-841. doi: 10.1080/10428194.2018.1508671.
    note
    Source null
    related pmid
    30234405
    relationship
    Comment in
outcomes validated
false
pmid
29672223
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
bee5cb21b259169793bc768700fb94bcfce34203fa6f639e0805c57ccec3b864
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Jun 1
precision
day
year
2018
publication types
  1. Journal Article
  2. Research Support, N.I.H., Extramural
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29672223/
title
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

Preserved source evidence · Independent clinical review pending · Not medical advice